A vs JNJ
Based on Invest's signal, Johnson & Johnson (JNJ) currently has the stronger Buy/Hold/Sell rating of the two — a buy versus buy for A.
| Metric | A | JNJ |
|---|---|---|
| Price | $160.00 | $270.00 |
| Day change | +2.3% | +0.0% |
| Market cap | $44.1B | $651.2B |
| P/E ratio | 31.6 | 31.3 |
| 1-year return | +26.3% | +52.4% |
| Invest signal | Buy | Buy |
Higher market cap, higher 1-year return, lower P/E, and a stronger signal are highlighted. Data is for learning, not financial advice.
Can't decide? Trade both — risk-free.
Start with €1,000,000 in virtual cash and practice buying A and JNJ at live prices.
A vs JNJ: FAQ
Is A or JNJ the better stock to buy?
Based on Invest's signal, Johnson & Johnson (JNJ) currently has the stronger Buy/Hold/Sell rating of the two — a buy versus buy for A. Remember that Invest's signal is a data-driven snapshot for learning, not financial advice — the best way to understand the difference is to add both to a watchlist and practice trading them with virtual cash.
Which is bigger, A or JNJ?
Johnson & Johnson is the larger company by market capitalisation ($651.2B vs $44.1B).
Can I practice trading A and JNJ for free?
Yes. Invest is a free stock market simulator — you start with €1,000,000 in virtual cash and can buy and sell both A and JNJ at live market prices, with no real money and no risk. It runs in your browser and as a free iOS app.